Lv1
66 积分 2023-10-14 加入
Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer
1个月前
已完结
Optimizing [212Pb]Pb-AB001 Radiopharmaceutical Therapy Schedules in PSMA-Positive Subcutaneous Prostate Cancer Xenografts
1个月前
已关闭
89 Zr/ 177 Lu-Labeled Radioimmunoconjugates Targeting SORT1 for Cancer Theranostics
4个月前
已完结
10P3Me: A GPC3-Targeted Peptide PET Probe for Subcutaneous and Orthotopic HCC Imaging
9个月前
已完结
皖公网安备34019202002308
